Head-to-head · WeighScore
Ivim Health vs MD Trim Clinic
The verdict
Ivim Health takes it — 59.6/100 to 56.1/100.
Ivim Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Ivim Health is a telehealth weight-loss programme selling compounded semaglutide starting at $149/mo and compounded tirzepatide starting at $224/mo, each quoted with medication and programme charges included.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Ivim Health | MD Trim Clinic |
|---|---|---|
| WeighScore | 59.6/100 | 56.1/100 |
| Grade | C | C |
| Scorecard rank | #338 | #421 |
| Semaglutide | $149/mo (starting dose, medication and programme fee, compounded) | Not disclosed |
| Tirzepatide | $224/mo (starting dose, medication and programme fee, compounded) | Not disclosed |
| Coverage | Coverage not published | 2 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #338 · C
Strengths
- Both molecules are priced on one page, each quoted as medication and programme charge included rather than as a bare drug price
- A six-month commitment brings tirzepatide down to $133/mo, and the term is published rather than hidden
- The first month of the membership is free
Where it loses points
- A $75/mo membership is marketed as a separate product, and whether it is charged on top of the $149 medication rate is not stated anywhere we could find
- The $133/mo tirzepatide rate advertised on the homepage requires a six-month commitment; the month-to-month rate is $224
- Both figures are 'starting at' rates, so the cost of a titrated dose is not published
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Graded #421 · C
Strengths
- Physician DO + NP team (Dr. Brandon Shaw, D.O. and Andrea Farris, N.P.) provides strong clinical oversight
- Compounded meds from LegitScript-certified pharmacies — higher supply-chain trust than many small practices
- Tiered dosing structure (Level 1 / Level 2) with B12 added to reduce nausea side effects
- Both telehealth and in-person options available (AZ Phoenix and CA Novato offices)
- Partnered mobile IV services available for enhanced nausea management and hydration support
Where it loses points
- Pricing not disclosed publicly — must contact clinic for quotes, limiting upfront comparison shopping
- Only AZ and CA confirmed — very limited geographic reach, excludes nearly all of the US
- No LegitScript certification for the clinic itself (only pharmacy partners are LegitScript-certified)
- Small practice with limited online presence and no published patient reviews or outcomes data
- No labs, coaching, or monitoring protocols disclosed on the site
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.